Skip to main content
Log in

Long non-coding RNA MEG3 induces renal cell carcinoma cells apoptosis by activating the mitochondrial pathway

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

This study aimed to examine the effect of long non-coding RNA (LncRNA) MEG3 on the biological behaviors of renal cell carcinoma (RCC) cells 786-0 and the possible mechanism. MEG3 expression levels were detected by RT-qPCR in tumor tissues and adjacent non-tumor tissues from 29 RCC patients and in RCC lines 786-0 and SN12 and human embryonic kidney cell line 293T. Plasmids GV144-MEG3 (MEG3 overexpression plasmid) and GV144 (control plasmid) were stably transfected into 786-0 cells by using lipofectamine 2000. Cell viabilities were determined by MTT, cell apoptosis rates by flow cytometry following PE Annexin V and 7AAD staining, apoptosis-related protein expressions by Western blotting, and Bcl-2 mRNA by RT-qPCR in the transfected cells. The results showed that MEG3 was evidently downregulated in RCC tissues (P<0.05) and RCC cell lines (P<0.05). The viabilities of 786-0 cells were decreased significantly after transfection with GV144-MEG3 for over 24 h (P<0.05). Consistently, the apoptosis rate was significantly increased in 786-0 cells transfected with GV144-MEG3 for 48 h (P<0.05). Furthermore, overexpression of MEG3 could reduce the expression of Bcl-2 and procaspase-9 proteins, enhance the expression of cleaved caspase-9 protein, and promote the release of cytochrome c protein to cytoplasm (P<0.05). Additionally, Bcl-2 mRNA level was declined by MEG3 overexpression (P<0.05). It was concluded that MEG3 induces the apoptosis of RCC cells possibly by activating the mitochondrial pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reeves DJ, Liu CY. Treatment of metastatic renal cell carcinoma. Cancer Chemother Pharmacol, 2009,64(1):11–25

    Article  CAS  PubMed  Google Scholar 

  2. Chen X, Ruan A, Wang X, et al. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. J Cancer Res Clin Oncol, 2014,140(8):1295–1304

    Article  CAS  PubMed  Google Scholar 

  3. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol, 2002,167(1):57–60

    Article  PubMed  Google Scholar 

  4. Cho IC, Chung J. Current status of targeted therapy for advanced renal cell carcinoma. Korean J Urol, 2012,53(4):217–228

    Article  PubMed Central  PubMed  Google Scholar 

  5. van Bakel H, Hughes TR. Establishing legitimacy and function in the new transcriptome. Brief Funct Genomic Proteomic, 2009,8(6):424–436

    Article  PubMed  Google Scholar 

  6. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science, 2007,316(5830):1488–1491

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Okamoto J, Hirata T, Chen Z, et al. EMX2 is epigenetically silenced and suppresses growth in human lung cancer. Oncogene, 2010,29(44):5969–5975

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Scheuermann JC, Boyer LA. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. Embo J, 2013,32(13):1805–1816

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 2011,10:38

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Yang QQ, Deng YF. Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers. Int J Clin Exp Pathol, 2014,7(4):1286–1292

    PubMed Central  PubMed  Google Scholar 

  11. Fang XY, Pan HF, Leng RX, et al. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett, 2015,356(2):357–366

    Article  CAS  PubMed  Google Scholar 

  12. Ronnau CG, Verhaegh GW, Luna-Velez MV, et al. Noncoding RNAs as novel biomarkers in prostate cancer. Biomed Res Int, 2014,2014:591703

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Schuster-Gossler K, Bilinski P, Sado T, et al. The mouse Gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA. Dev Dyn, 1998,212(2):214–228

    Article  CAS  PubMed  Google Scholar 

  14. Miyoshi N, Wagatsuma H, Wakana S, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells, 2000,5(3):211–220

    Article  CAS  PubMed  Google Scholar 

  15. Liu J, Wan L, Lu K, et al. The long noncoding RNA MEG3 contributes to cisplatin resistance of human lung adenocarcinoma. Plos One, 2015,10(5):0114586

    Google Scholar 

  16. Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem, 2012,113(6):1868–1874

    Article  CAS  PubMed  Google Scholar 

  17. Lu KH, Li W, Liu XH, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer, 2013,13:461

    Article  PubMed Central  PubMed  Google Scholar 

  18. Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene, 2011,30(47):4750–4756

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother, 2004,53(3):153–159

    Article  PubMed  Google Scholar 

  20. Blondeau JJ, Deng M, Syring I, et al. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma. Clin Epigenetics, 2015,7(1):10

    Article  PubMed Central  PubMed  Google Scholar 

  21. Qin R, Chen Z, Ding Y, et al. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma, 2013,60(5):486–492

    Article  CAS  PubMed  Google Scholar 

  22. He Y, Wu YT, Huang C, et al. Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis. Biochim Biophys Acta, 2014,1842(11):2204–2215

    Article  CAS  PubMed  Google Scholar 

  23. Zhang Y, Zou Y, Wang W, et al. Down-regulated long non-coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells. J Cell Biochem, 2015,116(4):542–550

    Article  CAS  PubMed  Google Scholar 

  24. Kawakami T, Chano T, Minami K, et al. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum Mol Genet, 2006,15(6):821–830

    Article  CAS  PubMed  Google Scholar 

  25. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 1999,399(6735):483–487

    Article  CAS  PubMed  Google Scholar 

  26. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev, 1999,13(15):1899–1911

    Article  CAS  PubMed  Google Scholar 

  27. Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell, 2011,21(1):92–101

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Budhram-Mahadeo V, Morris PJ, Smith MD, et al. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem, 1999,274(21):15237–15244

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fu-qing Zeng  (曾甫清).

Additional information

Both authors contributed equally to this work.

This project was supported by grants from the National Natural Science Foundation of China (Nos. 81001132, 81172423, and 81272816).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, M., Huang, T., Luo, G. et al. Long non-coding RNA MEG3 induces renal cell carcinoma cells apoptosis by activating the mitochondrial pathway. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 35, 541–545 (2015). https://doi.org/10.1007/s11596-015-1467-5

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-015-1467-5

Key words

Navigation